{"id":"NCT01736475","sponsor":"Baxalta now part of Shire","briefTitle":"Study Investigating a PEGylated Recombinant Factor VIII (BAX 855) for Hemophilia A (PROLONG-ATE Study)","officialTitle":"A Phase 2/3, Multi-Center, Open Label Study of Efficacy, Safety, and Pharmacokinetics of PEGylated Recombinant Factor VIII (BAX 855) Administered for Prophylaxis and Treatment of Bleeding in Previously Treated Patients With Severe Hemophilia A","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2013-01-31","primaryCompletion":"2014-07-17","completion":"2014-07-17","firstPosted":"2012-11-29","resultsPosted":"2016-09-07","lastUpdate":"2021-05-20"},"enrollment":159,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Hemophilia A"],"interventions":[{"type":"BIOLOGICAL","name":"Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method","otherNames":["ADVATE"]},{"type":"BIOLOGICAL","name":"PEGylated Recombinant Factor VIII","otherNames":["BAX 855"]},{"type":"BIOLOGICAL","name":"PEGylated Recombinant Factor VIII","otherNames":["BAX 855"]},{"type":"BIOLOGICAL","name":"PEGylated Recombinant Factor VIII","otherNames":["BAX 855"]}],"arms":[{"label":"Prophylaxis","type":"EXPERIMENTAL"},{"label":"On-demand","type":"EXPERIMENTAL"}],"summary":"To assess efficacy and safety, including immunogenicity of BAX 855 administered as prophylaxis and as on-demand therapy in adult and adolescent (12-65 years) previously treated patients (PTPs) with severe hemophilia A To determine the pharmacokinetic (PK) parameters of BAX 855.","primaryOutcome":{"measure":"Annualized Bleeding Rate (ABR)","timeFrame":"9 months","effectByArm":[{"arm":"Prophylaxis","deltaMin":4.3,"sd":null},{"arm":"On-demand","deltaMin":43.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"12 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":3},"locations":{"siteCount":72,"countries":["United States","Australia","Austria","Bulgaria","Czechia","Germany","Israel","Japan","Lithuania","Malaysia","Netherlands","Poland","Romania","South Korea","Spain","Sweden","Switzerland","Taiwan","Ukraine","United Kingdom"]},"refs":{"pmids":["26157075"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":137},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Headache"]}}